Related Experiment Videos
Classification and mechanism of action of antiarrhythmic drugs
1University of Hamburg, Department of Pharmacology, Germany.
Insights
This review explores antiarrhythmic drug classifications based on electrophysiological effects. It details how sodium channel blockers (class I) and other agents manage arrhythmias, noting ongoing debates in classification.
Area of Science:
- Pharmacology
- Cardiac Electrophysiology
Background:
- Antiarrhythmic agents are crucial for managing extrasystoles and tachyarrhythmias.
- Current classification systems are based on electrophysiological effects in cardiac tissues.
- The Vaughan Williams classification (1989) categorizes drugs by their impact on action potentials.
Purpose of the Study:
- To review the classification and mechanisms of action of antiarrhythmic drugs.
- To discuss the subclassification of class I agents based on their effects on action potential duration and recovery rates.
- To highlight ongoing debates regarding the classification of antiarrhythmic drugs, particularly classes I and III.
Main Methods:
- Review of existing literature on antiarrhythmic drug classification and mechanisms.
- Analysis of electrophysiological effects of drugs on isolated cardiac tissues.
- Examination of the frequency-dependent and state-dependent properties of class I agents.
Main Results:
- Antiarrhythmic drugs are classified into four main classes (I-IV) based on their primary electrophysiological targets.
- Class I agents (sodium channel blockers) are subclassified (IA-IC) based on action potential duration effects.
- Class I agents exhibit frequency-dependent effects due to modulated receptor binding, allowing subclassification into slow- and fast-recovery types.
Conclusions:
- The classification of antiarrhythmic drugs, especially classes I and III, remains a subject of debate.
- Slow-recovery class I agents can induce pro-arrhythmic effects by prolonging QRS duration and causing conduction disturbances.
- Understanding drug-specific interactions with ion channels is key to refining antiarrhythmic drug classification.
Abstract:
The present paper reviews classification and mode of action of agents that suppress extrasystoles and tachyarrhythmias. These are classified according to their electrophysiological effects observed in isolated cardiac tissues in vitro (Vaughan Williams, 1989). Fast sodium channel blockers (class I) which reduce the upstroke velocity of the action potential are usually subclassified into three groups, class I A-C, according to their effect on the action potential duration. Beta-adrenergic antagonists (class II) exert their effects by antagonizing the electrophysiological effects of beta-adrenergic catecholamines. Class III antiarrhythmic agents (eg amiodarone) prolong the action potential and slow calcium channel blockers (class IV) suppress the calcium inward current and calcium-dependent action potentials. The classification of antiarrhythmic drugs is still under debate. This particularly applies to agents of class I and III. The effect of class I agents is frequency-dependent because the binding affinity of these drugs to the sodium channel is modulated by the state of the channel (modulated receptor hypothesis). Class I agents bind to the channel in the activated and inactivated state and dissociate from the channel in the rested state. This occurs at a drug-specific rate so that class I agents can be subclassified into only two groups, namely in those of the slow- and fast-recovery type respectively (time constant of reactivation greater or smaller than 1 s). Slow-recovery class I agents affect regular action potentials at normal heart rates which can more easily lead to a lengthening of the QRS duration in the ECG, to conduction disturbances and hence to pro-arrhythmic effects.(ABSTRACT TRUNCATED AT 250 WORDS)